BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17394507)

  • 1. DCIS and LCIS with multinucleated giant cells-a report of 4 cases.
    Coyne JD
    Histopathology; 2007 Apr; 50(5):669-71. PubMed ID: 17394507
    [No Abstract]   [Full Text] [Related]  

  • 2. Microinvasive (T1mic) lobular carcinoma of the breast: clinicopathologic profile of 16 cases.
    Ross DS; Hoda SA
    Am J Surg Pathol; 2011 May; 35(5):750-6. PubMed ID: 21415700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LCIS found at core needle biopsy may not need surgical excision.
    Kopans DB
    AJR Am J Roentgenol; 2008 Sep; 191(3):W152; author reply W153. PubMed ID: 18716082
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
    Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
    Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
    Mechera R; Viehl CT; Oertli D
    Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A histopathological study for evaluation of therapeutic effects of radiofrequency ablation in patients with breast cancer.
    Tsuda H; Seki K; Hasebe T; Sasajima Y; Shibata T; Iwamoto E; Kinoshita T
    Breast Cancer; 2011 Jan; 18(1):24-32. PubMed ID: 20862572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.
    Wagner PL; Kitabayashi N; Chen YT; Shin SJ
    Am J Clin Pathol; 2009 Dec; 132(6):871-6. PubMed ID: 19926578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens.
    Brachtel EF; Rusby JE; Michaelson JS; Chen LL; Muzikansky A; Smith BL; Koerner FC
    J Clin Oncol; 2009 Oct; 27(30):4948-54. PubMed ID: 19720921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
    Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
    Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dilemma of lobular carcinoma in situ at percutaneous biopsy: to excise or to monitor.
    Gabriel H
    AJR Am J Roentgenol; 1999 Aug; 173(2):300-2. PubMed ID: 10430123
    [No Abstract]   [Full Text] [Related]  

  • 11. Multinucleated stromal giant cells in breast lesions.
    Ryska A
    Acta Cytol; 2003; 47(1):112-3. PubMed ID: 12585045
    [No Abstract]   [Full Text] [Related]  

  • 12. Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ.
    Aulmann S; Elsawaf Z; Penzel R; Schirmacher P; Sinn HP
    Am J Surg Pathol; 2009 Nov; 33(11):1646-53. PubMed ID: 19675453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multinucleation is an objective feature useful in the diagnosis of pleomorphic lobular carcinoma in situ.
    Blanco LZ; Thurow TA; Mahajan A; Susnik B; Helenowski I; Chmiel JS; Sullivan ME
    Am J Clin Pathol; 2015 Nov; 144(5):722-6. PubMed ID: 26486735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal carcinoma in situ of the breast with osteoclast-like giant cells.
    Krishnan C; Longacre TA
    Hum Pathol; 2006 Mar; 37(3):369-72. PubMed ID: 16613333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory breast carcinoma with extensive intraductal component: case report.
    Celik A; Kutun S; Pak I; Seki A; Cetin A
    Ultrastruct Pathol; 2004; 28(5-6):361-3. PubMed ID: 15764584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleomorphic lobular carcinoma in situ of the breast composed almost entirely of signet ring cells.
    Fadare O
    Pathol Int; 2006 Nov; 56(11):683-7. PubMed ID: 17040292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in 'pure' ductal carcinoma in situ of the breast.
    de Roos MA; van der Vegt B; Peterse JL; Patriarca C; de Vries J; de Bock GH; Wesseling J
    Histopathology; 2007 Aug; 51(2):227-38. PubMed ID: 17650217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
    Gonzalez LO; Corte MD; Junquera S; Bongera M; Rodriguez JC; Vizoso FJ
    Histopathology; 2007 Jun; 50(7):866-74. PubMed ID: 17543076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast.
    Kawasaki T; Oyama T; Nakagomi H; Furuya K; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Miyazawa T; Ishii Y; Fukushima K; Moriya T; Tsunoda H; Katoh R
    Pathol Int; 2011 Oct; 61(10):615-7. PubMed ID: 21951673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.